News Your AK Patients Can Use: FDA Approves Use of Up to Three Tubes of Biofrontera Inc.’s Ameluz in One Treatment
The U.S. Food and Drug Administration (FDA) has approved the use of up to three tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) topical gel, 10% in one treatment with the BF-RhodoLED or RhodoLED XL lamps. This is up from the previous maximum of one tube. Ameluz is recognized by the FDA for both lesion-directed […]